http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5614821-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02E30-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G21C3-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G21G1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G21G4-08
filingDate 2013-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-5614821-B1
titleOfInvention Uranium 233 manufacturing method, thorium nuclear fuel manufacturing method, medical radioisotope manufacturing method, and target plate manufacturing method for medical radioisotope manufacturing
abstract 【Task】 Provided is a method for producing uranium 233 in which the composition ratio of uranium 233 is 99% or more. [Solution] A thorium aggregate 100 made of metal thorium or a thorium-containing material is irradiated with neutrons, and 0.1 to 1% of the thorium 232 nuclei contained in the thorium aggregate 100 is transmuted into protoactinium 233 nuclei. The neutron irradiation process 10, the thorium assembly 100, the irradiated thorium assembly storage process 20 that stores the thorium assembly 100 for a period that is five times or more the half-life at which the protoactinium 233 nucleus decays into the uranium 233 nucleus, and the thorium assembly 100 to the uranium 233 And a uranium extraction process 30 for extracting. [Selection] Figure 1
priorityDate 2013-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005503568-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004534225-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415816814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577459
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415730023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID197096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454437300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415730022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23989
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415730075
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555225

Total number of triples: 52.